Oncology Steering Committee | Sermonix Pharmaceuticals

Sarat Chandarlapaty, MD, PhD

Laboratory/clinical oncologist developing new treatments for resistant breast cancers, Memorial Sloan-Kettering Cancer Center.

Massimo Cristofanilli, MD, FACP

Professor of Medicine, associate director of Translational Research, President of the Inflammatory Breast Cancer International Consortium (IBC-IC), president of the International Society of Liquid Biopsy (ISLB), Department of Medicine-Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University.

Stephanie Gaillard, MD, PhD

Assistant professor of Oncology, assistant professor of Gynecology and Obstetrics, director of Gynecologic Cancer Trials, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University.

Matthew Goetz, MD

Consultant, Division of Medical Oncology, Department of Oncology, professor of Oncology, co-leader, Women’s Cancer Program, co-principal investigator, Mayo Clinic Breast Cancer Specialization Program for Research Excellence, Mayo Clinic.

Shari Goldfarb, MD

Medical oncologist with research interests focusing on survivorship, sexual health, and quality of life issues in breast cancer patients, Memorial Sloan Kettering Cancer Center.

Geoffrey Greene, PhD

Virginia and D.K. Ludwig professor and chair, The Ben May Department of Cancer Research, professor, Department of Biochemistry and Molecular Biology, co-director, Ludwig Center for Metastasis Research, University of Chicago.

Elaine Mardis, PhD

Co-executive director, Institute for Genomic Medicine, Nationwide Children’s Hospital; professor Ohio State University, James Cancer Center; president, American Society for Cancer Research (AACR).

Hope Rugo, MD

Clinical professor, Department of Medicine (Hematology/Oncology); and director, Breast Oncology Clinical Trials Program, UCSF, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco.